Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Ertaczo 2% Cream 60 Gm By Valeant Pharma.

Image 0 of Ertaczo 2% Cream 60 Gm By Valeant Pharma. Image 1 of Ertaczo 2% Cream 60 Gm By Valeant Pharma.

Ertaczo 2% Cream 60 Gm By Valeant Pharma.

Call for Price

Ertaczo 2% Cream 60 Gm By Valeant Pharma. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXB10127225/RXD4929501/RXA391236
Size : 60 GM
Selling UoM : EA
NDC: 00187-5115-60
UPC Barcode : 301875115609
Supplier: 0050001428 VALEANT PHARMACEUTICALS INT'L
Supplier Material : 511560
Generic Code : 030866 SERTACONAZOLE NITRATE TOPICAL CREAM (G)
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX

Have a question?

  Call for Price

ERTACZO?
(sertaconazole nitrate) Cream, 2%.

For Topical Dermatologic Use Only - Not for Oral, Ophthalmic or Intravaginal Use
DRUG DESCRIPTION

ERTACZO? (sertaconazole nitrate) Cream, 2%, contains the imidazole antifungal, sertaconazole nitrate. Sertaconazole nitrate contains one asymmetric carbon atom and exists as a racemic mixture of equal amounts of R and S enantiomers.

Sertaconazole nitrate is designated chemically as (?)-1-[2,4-dichloro-β-[(7-chlorobenzo-[b]thien-3-yl)methoxy]phenethyl]imidazole nitrate. It has a molecular weight of 500.8.

Sertaconazole nitrate is a white or almost white powder. It is practically insoluble in water, sol-uble in methanol, sparingly soluble in alcohol and in methylene chloride. Each gram of ERTACZO? Cream, 2%, contains 17.5 mg of sertaconazole (as sertaconazole nitrate, 20 mg) in a white cream base of ethylene glycol and polyethylene glycol palmitostearate, glyceryl isostearate, light mineral oil, methylparaben, polyoxyethylened saturated glycerides and glycol-ized saturated glycerides, sorbic acid and purified water.

INDICATIONS

ERTACZO? (sertaconazole nitrate) Cream, 2%, is indicated for the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by: Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum (see Clinical Studies Section).
DOSAGE AND ADMINISTRATION

In the treatment of interdigital tinea pedis, ERTACZO? Cream, 2%, should be applied twice daily for 4 weeks. Sufficient ERTACZO? Cream, 2%, should be applied to cover both the affected areas between the toes and the immediately surrounding healthy skin of patients with interdig-ital tinea pedis. If a patient shows no clinical improvement 2 weeks after the treatment period, the diagnosis should be reviewed.


SIDE EFFECTS

In clinical trials, cutaneous adverse events occurred in 7 of 297 (2%) patients (2 of them severe) receiving ERTACZO? Cream, 2%, and in 7 of 291 (2%) patients (2 of them severe) receiving vehicle. These reported cutaneous adverse events included contact dermatitis, dry skin, burning skin, application site reaction and skin tenderness.

In a dermal sensitization study, 8 of 202 evaluable patients tested with ERTACZO? Cream, 2%, and 4 of 202 evaluable patients tested with vehicle, exhibited a slight erythematous reaction in the challenge phase. There was no evidence of cumulative irritation or contact sensitization in a repeated insult patch test involving 202 healthy volunteers. In non-US post-marketing surveillance for ERTACZO? Cream, 2%, the following cutaneous adverse events were reported: contact dermatitis, erythema, pruritus, vesiculation, desquamation, and hyperpigmentation.